In today’s briefing:
- Judo Capital Placement – Clean up but past Deal Didn’t Do Well
- Anthem Biosciences Pre-IPO – The Negatives- Margins Aren’t There Yet
- DN Solutions Pre-IPO – The Negatives – Stagnant Volumes
Judo Capital Placement – Clean up but past Deal Didn’t Do Well
- Bain and GIC looking to raise US$130m by selling their remaining stake in Judo Capital (JDO AU).
- The deal will be a large one to digest at 30.8 days of the stock’s three month ADV, representing 9.2% of its shares outstanding.
- In this note, we will talk about the placement and run the deal through our ECM framework.
Anthem Biosciences Pre-IPO – The Negatives- Margins Aren’t There Yet
- Anthem Biosciences (1234D IN) is looking to raise up to US$400m in its upcoming India IPO.
- Anthem Biosciences (ABS) is a contract research, development and manufacturing organisation (CRDMO) with fully integrated operations spanning drug discovery, development, and manufacturing.
- In this note, we talk about the not-so-positive aspects of the deal.
DN Solutions Pre-IPO – The Negatives – Stagnant Volumes
- DN Solutions (298440 KS) (DNS) aims to raise around US$1.1bn in its Korea IPO via selling a mix of primary and secondary shares.
- DNS is engaged in the manufacture and sale of machine tools and the business of automation solutions and services related thereto.
- In this note, we talk about the not-so-positive aspects of the deal.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
Unlock all research summaries